Liabilities, Current of Co-Diagnostics, Inc. from 31 Dec 2016 to 30 Sep 2025

Taxonomy & unit: us-gaap: USD
Description: Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
Summary: Co-Diagnostics, Inc. quarterly Liabilities, Current in USD history and change rate from 31 Dec 2016 to 30 Sep 2025.
Co-Diagnostics, Inc. Liabilities, Current for the quarter ending 30 Sep 2025 was $3,692,725, a 36% decline year-over-year.
Source SEC data: View on sec.gov

Liabilities, Current, Quarterly (USD)

Liabilities, Current, YoY Quarterly Change (%)

Co-Diagnostics, Inc. Quarterly Liabilities, Current (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q3 2025	$3,692,725	-$2,105,252	-36%	30 Sep 2025	10-Q	13 Nov 2025	2025	Q3
Q2 2025	$3,711,248	-$1,594,137	-30%	30 Jun 2025	10-Q	14 Aug 2025	2025	Q2
Q1 2025	$5,376,545	+$106,893	+2%	31 Mar 2025	10-Q	08 May 2025	2025	Q1
Q4 2024	$7,315,718	+$1,568,148	+27%	31 Dec 2024	10-Q	13 Nov 2025	2025	Q3
Q3 2024	$5,797,977	+$700,237	+14%	30 Sep 2024	10-Q	07 Nov 2024	2024	Q3
Q2 2024	$5,305,385	+$189,730	+3.7%	30 Jun 2024	10-Q	08 Aug 2024	2024	Q2
Q1 2024	$5,269,652	+$1,659,583	+46%	31 Mar 2024	10-Q	09 May 2024	2024	Q1
Q4 2023	$5,747,570	+$1,874,147	+48%	31 Dec 2023	10-K	27 Mar 2025	2024	FY
Q3 2023	$5,097,740	-$914,469	-15%	30 Sep 2023	10-Q	09 Nov 2023	2023	Q3
Q2 2023	$5,115,655	-$1,600,481	-24%	30 Jun 2023	10-Q	10 Aug 2023	2023	Q2
Q1 2023	$3,610,069	-$9,410,626	-72%	31 Mar 2023	10-Q	11 May 2023	2023	Q1
Q4 2022	$3,873,423	-$8,724,127	-69%	31 Dec 2022	10-K	14 Mar 2024	2023	FY
Q3 2022	$6,012,209	+$1,892,312	+46%	30 Sep 2022	10-Q	10 Nov 2022	2022	Q3
Q2 2022	$6,716,136	+$1,987,233	+42%	30 Jun 2022	10-Q	11 Aug 2022	2022	Q2
Q1 2022	$13,020,695	+$8,714,002	+202%	31 Mar 2022	10-Q	12 May 2022	2022	Q1
Q4 2021	$12,597,550	+$8,534,693	+210%	31 Dec 2021	10-K	16 Mar 2023	2022	FY
Q3 2021	$4,119,897	+$2,305,444	+127%	30 Sep 2021	10-Q	12 Nov 2021	2021	Q3
Q2 2021	$4,728,903	+$1,744,261	+58%	30 Jun 2021	10-Q	12 Aug 2021	2021	Q2
Q1 2021	$4,306,693	+$3,113,321	+261%	31 Mar 2021	10-Q	13 May 2021	2021	Q1
Q4 2020	$4,062,857	+$3,734,787	+1138%	31 Dec 2020	10-K	24 Mar 2022	2021	FY
Q3 2020	$1,814,453	+$1,506,569	+489%	30 Sep 2020	10-Q	16 Nov 2020	2020	Q3
Q2 2020	$2,984,642	+$2,672,563	+856%	30 Jun 2020	10-Q/A	03 Nov 2020	2020	Q2
Q1 2020	$1,193,372	+$855,861	+254%	31 Mar 2020	10-Q	14 May 2020	2020	Q1
Q4 2019	$328,070	-$2,023,913	-86%	31 Dec 2019	10-K	25 Mar 2021	2020	FY
Q3 2019	$307,884	-$1,882,091	-86%	30 Sep 2019	10-Q	12 Nov 2019	2019	Q3
Q2 2019	$312,079	+$21,512	+7.4%	30 Jun 2019	10-Q	14 Aug 2019	2019	Q2
Q1 2019	$337,511	+$51,172	+18%	31 Mar 2019	10-Q	14 May 2019	2019	Q1
Q4 2018	$2,351,983	+$1,723,727	+274%	31 Dec 2018	10-K	30 Mar 2020	2019	FY
Q3 2018	$2,189,975	+$1,512,957	+223%	30 Sep 2018	10-Q	14 Nov 2018	2018	Q3
Q2 2018	$290,567	-$4,383,628	-94%	30 Jun 2018	10-Q	10 Aug 2018	2018	Q2
Q1 2018	$286,339			31 Mar 2018	10-Q	14 May 2018	2018	Q1
Q4 2017	$628,256	-$3,217,157	-84%	31 Dec 2017	10-K	01 Apr 2019	2018	FY
Q3 2017	$677,018			30 Sep 2017	10-Q	14 Nov 2017	2017	Q3
Q2 2017	$4,674,195			30 Jun 2017	10-Q	25 Aug 2017	2017	Q2
Q4 2016	$3,845,413			31 Dec 2016	10-K	28 Mar 2018	2017	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.